White Paper

Long-Acting Muscarinic Agents (LAMAs) – A New Frontier for COPD and Asthma Treatment

May 9, 2014

Chronic obstructive pulmonary disease (COPD) is a major global health problem with a rising
incidence and morbidity representing an important public health challenge that is both preventable and treatable. It has been estimated that in 2030 COPD will be the fourth leading cause of death worldwide resulting in an economic and social burden that is both substantial and increasing.

Download to find out more.